Simon N.r. Harford - 11 Jan 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
CFO and Treasurer
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Jan 2022
Net transactions value
-$2,880
Form type
4
Filing time
11 Jan 2022, 16:38:15 UTC
Previous filing
12 Oct 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $2,880 -111 -0.87% $25.95 12,695 11 Jan 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 6,257 shares of common stock and 6,438 restricted stock units. Includes 192 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on November 30, 2021.